Enhancing the site financial process through streamlined, automated, cost-effective solutions.
Through rigorous negotiations, site's see an average increase of 30% on study budgets. By negotiating, analyzing, guiding, and reviewing your financial process, ClinEdge increases profitability by optimizing operations and allowing partners to focus on patient care and trial execution.
The ClinEdge Approach
Offering the tools and support services to provide end-to-end financial expertise across each spectrum of the research site business. ClinEdge represents your interests so you can focus on the conduct of high-quality research and excellence in patient care.
Contract & Budget Negotiations
Successful negotiations are critical to your site’s success, both in future opportunities and the current study. ClinEdge leverages our negotiating experience and Sponsor/CRO relationships to obtain the best possible result in budget and contract negotiations.
Study Receivables Management
Keeping your accounts receivable current is our priority! ClinEdge thoroughly reviews all contracts and budgets for payment language and holds the Sponsor/CRO to the agreed upon terms. It is our job to invoice timely, accurately and to aggressively follow up to make sure you get paid.
Study Reconciliation
At the end of each trial, ClinEdge completes a full study reconciliation to confirm all items have been invoiced and paid. We match your final withholding payment to your expected cash report, leaving nothing on the table and maximizing collected revenues.
Gain access to RealTime
CTMS to help organize and manage your clinical trial financial activities. ClinEdge will quality control the financials activities while providing monthly financial reports to your site. You will also have direct access to the RealTime-CTMS reporting tool which will allow you to generate your own reports as frequently as you would like.
Connect with us today!
Thank you for getting in touch!
Something wrong, please try again!
My position is most rewarding when sites are awarded competitive clinical trials in high interest indications. This not only helps their business to grow, but also continues to progress the future developments of clinical therapies.
